Brokerages Set Bio-Rad Laboratories, Inc. (NYSE:BIO) PT at $

Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) have been assigned a consensus recommendation of “Buy” from the four analysts that are currently covering the company, MarketBeat.com reports. Four investment analysts have rated the stock with a buy rating. The average 1-year price target among brokers that have issued a report on the […]

Related Keywords

United States , Canada , America , Michael Crowley , Adara Wright , Bio Rad Laboratories Inc , Bio Rad Laboratories Company Profile , Atlas Capital Advisors , Financial Services , Securities Exchange Commission , Pacific Center , Bio Rad Laboratories , Get Free Report , Exchange Commission , Capital Advisors , Finance Advisors , Dark Forest Capital Management , Forest Capital Management , Rad Laboratories , Get Free , Life Science , Clinical Diagnostics , Bio Rad Laboratories Daily , Nyse Bio , Bio , Medical , 09057220 , Ratings , Consensus ,